Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer

Clinical Endocrinology

Volumn 78, Issue 1, 2013, Pages 134-140

  Kim, Hye Jeong ^a   Kim, Na Kyung ^a   Choi, Ji Hun ^a   Sohn, Seo Young ^a   Kim, Se Won ^a   Jin, Sang Man ^a   Jang, Hye Won ^a   Suh, Sunghwan ^a   Min, Yong Ki ^a   Chung, Jae Hoon ^a   Kim, Sun Wook ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; IODINE; THYROTROPIN;

ADULT; AGE; ARTICLE; BODY MASS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL; UNDERWEIGHT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 84870948810     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04506.x     Document Type: Article

References (33)

1. Kilfoy, B.A., Zheng, T., Holford, T.R., et al. (2009) International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes and Control, 20, 525-531.
2. Enewold, L., Zhu, K., Ron, E., et al. (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology, Biomarkers and Prevention, 18, 784-791.
3. Cramer, J.D., Fu, P., Harth, K.C., et al. (2010) Analysis of the rising incidence of thyroid cancer using the surveillance, epidemiology and end results national cancer data registry. Surgery, 148, 1147-1152; discussion 1152-1143.
4. Abelson, P., &, Kennedy, D., (2004) The obesity epidemic. Science, 304, 1413.
5. Kitahara, C.M., Platz, E.A., Freeman, L.E., et al. (2011) Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiology, Biomarkers and Prevention, 20, 464-472.
6. Brindel, P., Doyon, F., Rachedi, F., et al. (2009) Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes and Control, 20, 581-590.
7. Renehan, A.G., Tyson, M., Egger, M., et al. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-578.
8. Oh, S.W., Yoon, Y.S., &, Shin, S.A., (2005) Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. Journal of Clinical Oncology, 23, 4742-4754.
9. Paes, J.E., Hua, K., Nagy, R., et al. (2010) The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. Journal of Clinical Endocrinology and Metabolism, 95, 4244-4250.
10. Kim, J.Y., Jung, E.J., Jeong, S.H., et al. (2011) The indices of body size and aggressiveness of papillary thyroid carcinoma. Journal of the Korean Surgical Society, 80, 241-244.
11. AJCC (American Joint Committee on Cancer). (2010) Thyroid. In:, S.B. Edge, D.R. Byrd, C.C. Compton, et al., eds. Cancer Staging Manual, 7th edn. Springer-Verlag, New York, 87-96.
12. World Health Organization Consultation on Obesity. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, 3-5 June 1997. In: World Health Organization; Geneva. p. 1-276.
13. Knudsen, N., Laurberg, P., Rasmussen, L.B., et al. (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism, 90, 4019-4024.
14. Fox, C.S., Pencina, M.J., D'Agostino, R.B., et al. (2008) Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Archives of Internal Medicine, 168, 587-592.
15. de Luca, C., &, Olefsky, J.M., (2008) Inflammation and insulin resistance. FEBS Letters, 582, 97-105.
16. Hill, R.N., Crisp, T.M., Hurley, P.M., et al. (1998) Risk assessment of thyroid follicular cell tumors. Environmental Health Perspectives, 106, 447-457.
17. Fiore, E., Rago, T., Provenzale, M.A., et al. (2009) Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer, 16, 1251-1260.
18. Hursting, S.D., Lashinger, L.M., Wheatley, K.W., et al. (2008) Reducing the weight of cancer: mechanistic targets for breaking the obesity- carcinogenesis link. Best Practice and Research. Clinical Endocrinology and Metabolism, 22, 659-669.
19. Rapp, K., Schroeder, J., Klenk, J., et al. (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia, 49, 945-952.
20. Stattin, P., Bjor, O., Ferrari, P., et al. (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care, 30, 561-567.
21. Barb, D., Williams, C.J., Neuwirth, A.K., et al. (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. American Journal of Clinical Nutrition, 86, s858-s866.
22. Dossus, L., &, Kaaks, R., (2008) Nutrition, metabolic factors and cancer risk. Best Practice and Research. Clinical Endocrinology and Metabolism, 22, 551-571.
23. Paz-Filho, G., Lim, E.L., Wong, M.L., et al. (2011) Associations between adipokines and obesity-related cancer. Frontiers in Bioscience, 16, 1634-1650.
24. Akinci, M., Kosova, F., Cetin, B., et al. (2009) Leptin levels in thyroid cancer. Asian Journal of Surgery, 32, 216-223.
25. Cheng, S.P., Chi, C.W., Tzen, C.Y., et al. (2010) Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery, 147, 847-853.
26. Uddin, S., Bavi, P., Siraj, A.K., et al. (2010) Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocrine-Related Cancer, 17, 191-202.
27. Bouloumie, A., Drexler, H.C., Lafontan, M., et al. (1998) Leptin, the product of Ob gene, promotes angiogenesis. Circulation Research, 83, 1059-1066.
28. Wei, E.K., Giovannucci, E., Fuchs, C.S., et al. (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. Journal of the National Cancer Institute, 97, 1688-1694.
29. Tworoger, S.S., Eliassen, A.H., Kelesidis, T., et al. (2007) Plasma adiponectin concentrations and risk of incident breast cancer. Journal of Clinical Endocrinology and Metabolism, 92, 1510-1516.
30. Spyridopoulos, T.N., Petridou, E.T., Skalkidou, A., et al. (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. International Journal of Cancer, 120, 1573-1578.
31. Michalakis, K., Williams, C.J., Mitsiades, N., et al. (2007) Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiology, Biomarkers and Prevention, 16, 308-313.
32. Mitsiades, N., Pazaitou-Panayiotou, K., Aronis, K.N., et al. (2000) Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism, 96, E2023-E2028.
33. Brakenhielm, E., Veitonmaki, N., Cao, R., et al. (2004) Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 101, 2476-2481.